Rated 2.5 / 5 (How Ratings Work)
Possible to probable range of efficacy of cannabis for treatment of addiction to heroin.
Based on 12 Studies from 1976 - 2017
Study Name, Description & Year
Rating
Cannabidiol: Swinging The Marijuana Pendulum From 'Weed' To Medication To Treat The Opioid Epidemic
Review — 2017
The Endocannabinoid System As A Target For Addiction Treatment: Trials And Tribulations
Review — 2017
Cannabinoid And Opioid Interactions: Implications For Opiate Dependence And Withdrawal
Review/Meta-Analysis — 2013
Cannabidiol, A Nonpsychotropic Component Of Cannabis, Inhibits Cue-induced Heroin Seeking And Normalizes Discrete Mesolimbic Neuronal Disturbances
Animal study (rats) — 2009
Neural Basis Of Delta-9-tetrahydrocannabinol And Cannabidiol: Effects During Response Inhibition
A double-blind, pseudo-randomized, placebo-controlled trial conducted on 15 healthy human volunteers. — 2008
Modulation Of Oral Morphine Antinociceptive Tolerance And Naloxone-precipitated Withdrawal Signs By Oral Delta 9-tetrahydrocannabinol
Animal study (mice) — 2003
Attenuation Of Spontaneous Opiate Withdrawal In Mice By The Anandamide Transport Inhibitor AM404
Animal study (mice) — 2002
Delta9-tetrahydrocannabinol Releases And Facilitates The Effects Of Endogenous Enkephalins: Reduction In Morphine Withdrawal Syndrome Without Change In Rewarding Effect
Animal study (rats) — 2001
Opioid And Cannabinoid Modulation Of Precipitated Withdrawal In Delta(9)-tetrahydrocannabinol And Morphine-dependent Mice
Animal study (mice) — 2001
Endogenous Cannabinoid, 2-arachidonoylglycerol, Attenuates Naloxone-precipitated Withdrawal Signs In Morphine-dependent Mice
Animal study (mice) — 2001
Anandamide Decreases Naloxone-precipitated Withdrawal Signs In Mice Chronically Treated With Morphine
Animal study (mice) — 1995
Correlation Between The In Vivo And An In Vitro Expression Of Opiate Withdrawal Precipitated By Naloxone: Their Antagonism By L-(-)-delta9-tetrahydrocannabinol
Animal Study (Guinea pigs) — 1976